Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines that address treatment resistance and improve selectivity against validated kinase targets. The company applies structure-based drug design and collaborates with clinical researchers to create therapies for patients whose cancers are driven by specific genetic alterations. Its pipeline includes investigational treatments for ROS1-positive, ALK-positive, and HER2-altered cancers, with programs spanning multiple stages of clinical development. Nuvalent also conducts clinical trials and research activities focused on expanding treatment options for patients with solid tumors and other oncology indications.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
228
Frequently Asked Questions
What is Market Cap of Nuvalent Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Nuvalent Inc - Ordinary Shares - Class A market cap is $9.79B.
What is the 52-week high for Nuvalent Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nuvalent Inc - Ordinary Shares - Class A 52 week high is $123.99 as of July 21, 2026.
What is the 52-week low for Nuvalent Inc - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nuvalent Inc - Ordinary Shares - Class A 52 week low is $71.13 as of July 21, 2026.
What is Nuvalent Inc - Ordinary Shares - Class A stock price today?
Nuvalent Inc - Ordinary Shares - Class A stock price today is $123.96.
What was Nuvalent Inc - Ordinary Shares - Class A stock price yesterday?
Nuvalent Inc - Ordinary Shares - Class A stock price yesterday was $123.94.
What is the PE ratio of Nuvalent Inc - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Nuvalent Inc - Ordinary Shares - Class A's P/E ratio is -20.46.
What is the Price-to-Book ratio of Nuvalent Inc - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Nuvalent Inc - Ordinary Shares - Class A P/B ratio is 8.3264.
What is the 50-day moving average of Nuvalent Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Nuvalent Inc - Ordinary Shares - Class A 50-day moving average is $113.49.
How many employees does Nuvalent Inc - Ordinary Shares - Class A have?
Nuvalent Inc - Ordinary Shares - Class A has 228 employees.